Metagenics, FTC settle Bone Builder supplement claims case in final consent agreement.
This article was originally published in The Tan Sheet
Executive Summary
METAGENICS, FTC SETTLE BONE BUILDER CLAIMS CASE in a final consent order approved in a 3-0 vote by the Federal Trade Commission. One commissioner member abstained. The commission announced Oct. 31 that it has settled its action against Metagenics, doing business as Ethical Nutrients, related to "effectiveness" claims made for the Bone Builder calcium supplement. The case was contentious at times and the settlement is the result of extended discussion between the company and the agency.